Stock: Page 4

Siemens revenue falls 7% in third quarter
By LabPulse.com staff writers
For the period (end-June 30), Siemens Healthineers posted revenues of 3.312 billion euros ($3.893 billion U.S.), down 7.2% compared with revenues of 3.569 billion ($4.196 billion) in the third quarter of 2019, and down 6.9% after adjusting for currency effects. The company's net income was 271 million euros ($318.6 million), down compared with 353 million euros ($414.9 million) in the corresponding quarter of 2019.
August 2, 2020
2020 01 15 23 19 8499 Siemens Rsna 2019 400
Chembio hit with class-action lawsuit over COVID-19 antibody tests
By LabPulse.com staff writers
Filed by the Portnoy Law Firm, the complaint alleges that Chembio misled investors on the accuracy of its Dual Path Platform (DPP) COVID-19 serological point-of-care-test for detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies. Then in May, Chembio raised approximately $30.8 million in gross proceeds from a public offering, according to the law firm.
July 21, 2020
2020 07 22 15 50 6516 Lawsuit 400
BD revenues edge up for 2nd quarter
By LabPulse.com staff writers
For the quarter, BD reported sales of $4.253 billion, up 1.4% from $4.195 billion in the same period of 2019. The company's net income was $183 million, compared with $20 million in the corresponding quarter of 2019.
May 6, 2020
2019 08 20 21 56 4986 Becton Aacc 2019 400
Quanterix to make $75M public offering
By LabPulse.com staff writers
The company will grant underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock at the public offering price, it said; all shares will be sold by Quanterix.
August 7, 2019
2019 08 08 20 08 1464 Stock Exchange 400
Previous Page
Page 4 of 4